Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A37683 | 24672082 | Curr Ther Res Clin Exp | Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients. | 2004 | Details |
| A37708 | 15066643 | Eur J Intern Med | Non-alcoholic steatohepatitis: review of a growing medical problem. | 2004 | Details |
| A37721 | 15044174 | Am J Physiol Gastrointest Liver Physiol | Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. | 2004 | Details |
| A37795 | 14638353 | Am J Gastroenterol | Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. | 2003 | Details |
| A37815 | 14593532 | Turk J Gastroenterol | Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis. | 2003 | Details |
| A37835 | 14512888 | Hepatology | Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. | 2003 | Details |
| A37848 | 12970903 | World J Gastroenterol | Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. | 2003 | Details |
| A37875 | 12891546 | Gastroenterology | Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. | 2003 | Details |
| A37879 | 12883485 | Hepatology | Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. | 2003 | Details |
| A37895 | 12836490 | Acta Clin Belg | Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists. | 2003 | Details |
| A37911 | 12792703 | Braz J Med Biol Res | Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis. | 2003 | Details |
| A38046 | 12409257 | Mol Ther | Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis. | 2002 | Details |
| A38067 | 12353831 | Dig Dis Sci | Liver regeneration is not altered in patients with nonalcoholic steatohepatitis (NASH) when compared to chronic hepatitis C infection with similar grade of inflammation. | 2002 | Details |
| A38149 | 12045779 | Can J Gastroenterol | Nonalcoholic steatohepatitis in nondiabetic obese patients. | 2002 | Details |
| A38186 | 11944630 | Semin Gastrointest Dis | Diabetes mellitus, obesity, and hepatic steatosis. | 2002 | Details |
| A38220 | 11873108 | J Clin Gastroenterol | Update on nonalcoholic fatty liver disease. | 2002 | Details |
| A38292 | 11676329 | Indian J Gastroenterol | Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. | 2001 | Details |
| A38294 | 11668021 | Am J Physiol Gastrointest Liver Physiol | Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. | 2001 | Details |
| A38320 | 11569700 | Am J Gastroenterol | Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. | 2001 | Details |
| A38417 | 11296694 | Semin Liver Dis | Etiopathogenesis of nonalcoholic steatohepatitis. | 2001 | Details |
| A38439 | 11242127 | Zhonghua Gan Zang Bing Za Zhi | The role of Kupffer cells in non-alcoholic steatohepatitis of rats chronically fed with high-fat diet. | 2001 | Details |
| A38442 | 11232700 | Am J Gastroenterol | A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. | 2001 | Details |
| A38502 | 11097727 | Curr Treat Options Gastroenterol | Non-Alcoholic Steatohepatitis (NASH). | 1999 | Details |
| A38563 | 10923919 | Hum Pathol | Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver. | 2000 | Details |
| A38606 | 10799085 | Can J Gastroenterol | Nonalcoholic steatohepatitis: an evolving diagnosis. | 2000 | Details |
| A38725 | 10484010 | Am J Gastroenterol | Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. | 1999 | Details |
| A38792 | 10074181 | J Virol | Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. | 1999 | Details |
| A38961 | 9436007 | Gastroenterologist | Nonalcoholic fatty liver (NASH syndrome). | 1997 | Details |
| A39799 | 1577855 | J Cell Biol | Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways. | 1992 | Details |
| A40900 | 6753683 | Ann Intern Med | Schistosome infections in humans: perspectives and recent findings. NIH conference. | 1982 | Details |
| A42201 | 35256849 | Diabetes Metab Syndr Obes | MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients. | 2022 | Details |
| A42202 | 35247475 | J Ethnopharmacol | The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease. | 2022 | Details |
| A42212 | 35203056 | Am J Trop Med Hyg | Involvement of the Liver in COVID-19: A Systematic Review. | 2022 | Details |
| A42218 | 35185572 | Front Pharmacol | Protective Effect of Isoorientin on Oleic Acid-Induced Oxidative Damage and Steatosis in Rat Liver Cells. | 2022 | Details |
| A42226 | 35169106 | Am J Gastroenterol | Evolutionary medicine perspectives: H. pylori, lactose intolerance, and three hypotheses for functional and inflammatory gastrointestinal and hepatobiliary disorders. | 2022 | Details |
| A42229 | 35165436 | Nat Rev Gastroenterol Hepatol | Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. | 2022 | Details |
| A42234 | 35146047 | Open Forum Infect Dis | Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. | 2022 | Details |
| A42263 | 35046902 | Front Endocrinol (Lausanne) | Molecular and Cellular Bases of Lipodystrophy Syndromes. | 2022 | Details |
| A42269 | 35039631 | Cell Mol Immunol | Neutrophils in chronic inflammatory diseases. | 2022 | Details |
| A42274 | 35022960 | Mol Cell Biochem | Autophagy: a molecular switch to regulate adipogenesis and lipolysis. | 2022 | Details |
| A42292 | 34955407 | Int Immunopharmacol | Corrigendum to "Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3" [Int. Immunopharmacol. 100 (2021) 108126]. | 2021 | Details |
| A42297 | 34935193 | Fundam Clin Pharmacol | Hepatoprotective and therapeutic effects of resveratrol: A focus on anti-inflammatory and antioxidative activities. | 2022 | Details |
| A42309 | 34911389 | J Investig Med High Impact Case Rep | Overlap of Psoriatic Arthritis and Dermatomyositis. | 2021 | Details |
| A42316 | 34894107 | Hepatol Commun | MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells. | 2021 | Details |
| A42330 | 34850389 | FEBS Lett | Immune cell profile and immune-related gene expression of obese peripheral blood and liver tissue. | 2021 | Details |
| A42337 | 34825869 | Curr Drug Metab | Regulatory Effects of N-3 PUFAs on Pancreatic β-cells and Insulin-sensitive Tissues. | 2021 | Details |
| A42353 | 34779503 | Mol Med Rep | Efferocytosis in multisystem diseases (Review). | 2021 | Details |
| A42359 | 34767670 | Biofactors | Vitamin D3 enhances the effects of omega-3 oils against metabolic dysfunction-associated fatty liver disease in rat. | 2021 | Details |
| A42362 | 34764874 | Front Pharmacol | Carnitine Palmitoyltransferase System: A New Target for Anti-Inflammatory and Anticancer Therapy? | 2021 | Details |
| A42402 | 34633856 | Annu Rev Nutr | Microbial Flavonoid Metabolism: A Cardiometabolic Disease Perspective. | 2021 | Details |
| A42403 | 34630116 | Front Pharmacol | An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism. | 2021 | Details |
| A42420 | 34572393 | Biomedicines | Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease. | 2021 | Details |
| A42422 | 34572325 | Biomedicines | Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations. | 2021 | Details |
| A42428 | 34550600 | J Cell Physiol | The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases. | 2021 | Details |
| A42456 | 34486131 | Alcohol Clin Exp Res | Trehalose activates hepatic transcription factor EB (TFEB) but fails to ameliorate alcohol-impaired TFEB and liver injury in mice. | 2021 | Details |
| A42469 | 34455076 | Pharmacol Res | The pivotal role of Nrf2 activators in adipocyte biology. | 2021 | Details |
| A42476 | 34439969 | Biology (Basel) | Aldehyde Dehydrogenase Mutation Exacerbated High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease with Gut Microbiota Remodeling in Male Mice. | 2021 | Details |
| A42500 | 34362163 | J Clin Med | Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy. | 2021 | Details |
| A42509 | 34331682 | Adv Exp Med Biol | Turmeric and Curcumin: From Traditional to Modern Medicine. | 2021 | Details |
| A42526 | 34261897 | Curr Opin Pediatr | Managing abnormal liver tests in children with inflammatory bowel disease. | 2021 | Details |
| A42529 | 34239266 | World J Gastroenterol | Neuropilin-1: A feasible link between liver pathologies and COVID-19. | 2021 | Details |
| A42548 | 34183378 | Drug Metab Dispos | Silybin Restored CYP3A Expression through the Sirtuin 2/Nuclear Factor κ-B Pathway in Mouse Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42560 | 34162770 | Biomol Ther (Seoul) | Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders. | 2021 | Details |
| A42598 | 34070749 | Int J Mol Sci | Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis. | 2021 | Details |
| A42622 | 33986456 | Int J Obes (Lond) | Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients. | 2021 | Details |
| A42628 | 33967796 | Front Pharmacol | Innate Immunity in Diabetic Wound Healing: Focus on the Mastermind Hidden in Chronic Inflammatory. | 2021 | Details |
| A42638 | 33933727 | Clin Nutr | Gender and gut microbiota composition determine hepatic bile acid, metabolic and inflammatory response to a single fast-food meal in healthy adults. | 2021 | Details |
| A42641 | 33925340 | Molecules | The Health-Promoting Properties and Clinical Applications of Rice Bran Arabinoxylan Modified with Shiitake Mushroom Enzyme-A Narrative Review. | 2021 | Details |
| A42642 | 33919641 | Diagnostics (Basel) | Associations between Pre-Bariatric High-Sensitivity C-Reactive Protein and Post-Surgery Outcomes. | 2021 | Details |
| A42643 | 33916086 | Int J Mol Sci | Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice. | 2021 | Details |
| A42654 | 33869980 | J Endocr Soc | Removal of Epididymal Visceral Adipose Tissue Prevents Obesity-Induced Multi-organ Insulin Resistance in Male Mice. | 2021 | Details |
| A42663 | 33856704 | J Periodontol | Food restriction reduces hepatic alterations associated with experimental periodontitis. | 2021 | Details |
| A42667 | 33847628 | Medicine (Baltimore) | Global research status of gastroenterology and hepatology: A bibliometrics study. | 2021 | Details |
| A42685 | 33784425 | J Leukoc Biol | HMGB1: An overview of its roles in the pathogenesis of liver disease. | 2021 | Details |
| A42703 | 33717101 | Front Immunol | Natural Killer Cells: Friend or Foe in Metabolic Diseases? | 2021 | Details |
| A42721 | 33649876 | Inflammation | Neutrophil-Induced Liver Injury and Interactions Between Neutrophils and Liver Sinusoidal Endothelial Cells. | 2021 | Details |
| A42749 | 33586126 | Am J Clin Dermatol | Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges. | 2021 | Details |
| A42780 | 33497712 | Metabolism | Role of the gut microbiota in type 2 diabetes and related diseases. | 2021 | Details |
| A42799 | 33445170 | J Clin Invest | Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer. | 2021 | Details |
| A42845 | 33309167 | J Genet Genomics | Comprehensive lipidomics in apoM-/- mice reveals an overall state of metabolic distress and attenuated hepatic lipid secretion into the circulation. | 2020 | Details |
| A42878 | 33228942 | Pediatr Clin North Am | Pulmonary Manifestations of Gastrointestinal, Pancreatic, and Liver Diseases in Children. | 2021 | Details |
| A42882 | 33220249 | Metabolism | Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19. | 2020 | Details |
| A42913 | 33117357 | Front Immunol | Role of the Nuclear Receptor Corepressor 1 (NCOR1) in Atherosclerosis and Associated Immunometabolic Diseases. | 2020 | Details |
| A42920 | 33089485 | Dig Dis Sci | Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD. | 2020 | Details |
| A42975 | 32914727 | Endocr Metab Immune Disord Drug Targets | Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine. | 2021 | Details |
| A42996 | 32864357 | World J Transplant | Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation. | 2020 | Details |
| A43002 | 32845785 | J Interferon Cytokine Res | Key Players of Hepatic Fibrosis. | 2020 | Details |
| A43015 | 32812686 | FASEB J | GPR91, a critical signaling mechanism in modulating pathophysiologic processes in chronic illnesses. | 2020 | Details |
| A43032 | 32758101 | J Am Coll Nutr | Interplay Between Insulin Resistance and Body Fat Mass in Evolution of Perturbations Linked to the Metabolic Syndrome in Non-Diabetics: Emphasis on Inflammatory Factors. | 2020 | Details |
| A43035 | 32751062 | Int J Mol Sci | Consumption of Wild Rice (Zizania latifolia) Prevents Metabolic Associated Fatty Liver Disease through the Modulation of the Gut Microbiota in Mice Model. | 2020 | Details |
| A43053 | 32693115 | J Ethnopharmacol | A review of the processed Polygonum multiflorum (Thunb.) for hepatoprotection: Clinical use, pharmacology and toxicology. | 2020 | Details |
| A43057 | 32690129 | Gene Expr | Epidemiological Realities of Alcoholic Liver Disease: Global Burden, Research Trends, and Therapeutic Promise. | 2020 | Details |
| A43060 | 32668973 | Am J Chin Med | Gastrodin Pretreatment Protects Liver Against Ischemia-Reperfusion Injury via Activation of the Nrf2/HO-1 Pathway. | 2020 | Details |
| A43074 | 32624568 | Exp Mol Med | Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. | 2020 | Details |
| A43098 | 32571750 | Clin Res Hepatol Gastroenterol | Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis. | 2020 | Details |
| A43105 | 32558697 | Eur J Gastroenterol Hepatol | COVID-19 and the liver: overview. | 2021 | Details |
| A43107 | 32553811 | Eur J Pharmacol | The effect of emodin on liver disease -- comprehensive advances in molecular mechanisms. | 2020 | Details |
| A43123 | 32507608 | Eur J Intern Med | Hepatic consequences of COVID-19 infection. Lapping or biting? | 2020 | Details |
| A43143 | 32440694 | Inflamm Bowel Dis | Implications of Dietary Impact on Hepatic Steatosis and IBD. | 2021 | Details |
| A43175 | 32368680 | Arch Med Sci Atheroscler Dis | Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden. | 2019 | Details |